Identification and Characterization of an Inhibitor of Eukaryotic Elongation Factor 2 Kinase against Human Cancer Cell Lines

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6894-6899

  Arora, Sonia ^a   Yang, Jin Ming ^a   Kinzy, Terri Goss ^a   Utsumi, Ryutaro ^b   Okamoto, Tadashi ^b   Kitayama, Takashi ^b   Ortiz, Pedro A ^a   Hait, William N ^a,c  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b KINKI UNIVERSITY   (Japan)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLIMIDAZOLIUM DERIVATIVE; ANTINEOPLASTIC AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE; ELONGATION FACTOR 2; ELONGATION FACTOR 2 KINASE INHIBITOR; IMIDAZOLE DERIVATIVE; NH 125; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN HISTIDINE KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN KINASE C; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE MUTATION; GENE OVEREXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT;

ANTINEOPLASTIC AGENTS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; HUMANS; IMIDAZOLES; PHOSPHORYLATION;

EID: 0142219876     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. r 100,000 substrate for calmodulin-dependent protein kinase III in mammalian cells as elongation factor-2. J. Biol. Chem., 262: 17299-17303, 1987.
2. Redpath, N. T., and Proud, C. G. Purification and phosphorylation of elongation factor-2 kinase from rabbit reticulocytes. Eur. J. Biochem. 212: 511-520, 1993.
3. Ryazanov, A. G., Shestakova, E. A., and Natapov, P. G. Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation. Nature (Lond.), 334: 170-173, 1988.
4. Bagaglio, D. M., Cheng, E. H., Gorelick, F. S., Mitsui, K., Nairn, A. C., and Hait, W. N. Phosphorylation of elongation factor 2 in normal and malignant rat glial cells. Cancer Res., 53: 2260-2264, 1993.
5. Parmer, T. G., Ward, M. D., Yurkow, E. J., Vyas, V. H., Kearney, T. J., and Hait. W. N. Activity and regulation by growth factors of calmodulin-dependent protein kinase III (elongation factor 2-kinase) in human breast cancer. Br. J. Cancer, 79: 59-64, 1999.
6. Hait, W. N., Ward, M. D., Trakht, I. N., and Ryazanov, A. G. Elongation factor-2 kinase: immunological evidence for the existence of tissue-specific isoforms. FEBS Lett., 397: 55-60, 1996.
7. Bagaglio, D. M., and Hait, W. N. Role of calmodulin-dependent phosphorylation of elongation factor 2 in the proliferation of rat glial cells. Cell Growth Differ., 5: 1403-1408, 1994.
8. Calberg, U., Nilsson, A., Skog, S., Palmquist, K., and Nygard, O. Increased activity of the eEF-2 specific, Ca2+ and calmodulin dependent protein kinase III during the S-phase in Ehrlich ascites cells. Biochem. Biophys. Res. Commun., 180: 1372-1376, 1991.
9. Celis, J. E., Madsen, P., and Ryazanov, A. G. Increased phosphorylation of elongation factor 2 during mitosis in transformed human amnion cells correlates with a decreased rate of protein synthesis. Proc. Natl. Acad. Sci. USA, 87: 4231-4235, 1990.
10. Brady, M. J., Nairn, A. C., Wugner, J. A., and Palfrey, H. C. Nerve growth factor-induced down-regulation of calmodulin-dependent protein kinase III in PC12 cells involves cyclic AMP-dependent protein kinase. J. Neurochem., 54: 1034-1039, 1990.
11. Severinov, K. V., Melnikova, E. G., and Ryazanov, A. G. Down-regulation of the translation elongation factor 2 kinase in Xenopus laevis oocytes at the final stages of oogenesis. New Biol., 2: 887-893, 1990.
12. Parmer, T. G., Ward, M. D., and Hait, W. N. Effects, of rottlerin, an inhibitor of calmodulin-dependent protein kinase III, on cellular proliferation, viability, and cell cycle distribution in malignant glioma cells. Cell Growth Differ., 8: 327-334, 1997.
13. Yang, J., Yang, J. M., Iannone, M., Shih, W. J., Lin, Y., and Hait. W. N. Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin. Cancer Res., 61: 4010-4016, 2001.
14. Ryazanov, A. G., Ward, M. D., Mendola, C. E., Pavur, K. S., Dorovkov, M. V., Wiedmann, M., Erdjument-Bromage, H., Tempst, P., Parmer, T. G., Prostko, C. R., Germino, F. I., and Hait, W. N. Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase. Proc. Natl. Acad. Sci. USA, 94: 4884-4889, 1997.
15. Pavur, K. S., Petrov, A. N., and Ryazanov, A. G. Mapping the functional domains of elongation factor-2 kinase. Biochemistry, 39: 12216-12224, 2000.
16. Ryazanov, A. G., Pavur, K. S., and Dorovkov, M. V. α-Kinases: a new class of protein kinases with a novel catalytic domain. Curr. Biol., 9: R43-R45, 1999.
17. Yamamoto, K., Kitayama, T., Ishida, N., Watanabe, T., Tanabe, H., Takatani, M., Okamoto, T., and Utsumi, R. Identification and characterization of a potent antibacterial agent, NH 125 against drug-resistant bacteria. Biosci. Biotechnol. Biochem., 64: 919-923, 2000.
18. Jorgensen, R., Carr-Schmid, A., Ortiz, P. A., Kinzy, T. G., and Anderson, O. R. Purification and crystallization of the yeast elongation factor eEF2. Acta Crystallogr. D Biol. Crystallogr., 58: 712-715, 2002.
19. Caraglia, M., Budillon, A., Vitale, G., Lupoli, G., Tagliaferri, P., and Abbruzzese, A. Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation. Eur. J. Biochem., 267: 3919-3936, 2000.
20. Palfrey, H. C., Nairn, A. C., Muldoon, L. L., and Villereal, M. L. Rapid activation of calmodulin-dependent protein kinase III in mitogen-stimulated human fibroblasts. Correlation with intracellular Ca2+ transients. J. Biol. Chem., 262: 9785-9792, 1987.
21. Yamaguchi, H., Matsushita, M., Nairn, A. C., and Kuriyan, J. Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity. Mol. Cell, 7: 1047-1057, 2001.
22. Gschwendt, M., Kittstein, W., and Marks, F. Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine. FEBS Lett., 338: 85-88, 1994.
23. Cho, S. I., Koketsu, M., Ishihara, H., Matsushita, M., Nairn, A. C., Fukazawa, H., and Uehara, Y. Novel compounds, '1,3-selenazine derivatives' as specific inhibitors of eukaryotic elongation factor-2 kinase. Biochim. Biophys. Acta, 1475: 207-215, 2000.